Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-30 @ 5:25 AM
Study NCT ID:
NCT05118958
Status:
COMPLETED
Last Update Posted:
2021-11-12
First Post:
2021-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations
Sponsor:
KalVista Pharmaceuticals, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-26
First Submit QC Date:
None
Study First Post Date:
2021-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-03
Last Update Post Date:
2021-11-12
Last Update Post Date Type:
ACTUAL